ArticlePharmacoEconomics2023

Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.

Aurelie Meunier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.